Health Highlights: Feb. 27, 2009

Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

Drug Maker Suppressed Data on Antipsychotic: Report

Unfavorable studies on the antipsychotic drug Seroquel were "buried" by U.K.-based drug maker AstraZeneca Plc, according to a December 1999 e-mail unsealed Thursday as part of legal action over the drug, the Bloomberg news service reported.

AstraZeneca faces about 9,000 lawsuits claiming the company failed to properly warn patients that the drug can cause diabetes and other health problems.

In the e-mail, AstraZeneca publications manager John Tumas said the company failed to publicize results of at least three clinical trials of Seroquel and selectively chose data from one of the studies for use in a presentation, Bloomberg reported.

WHAT TO KNOW
    • Drug Maker Suppressed Data on Antipsychotic: Report
    • White House to Rescind Health Worker Conscience Rule
    • Black Box Warning Ordered For Heartburn Drug
    • Economy Pushing Americans to Cut Needed Health Care

"The larger issue is how we face the outside world when they begin to criticize us for suppressing data," Tumas wrote in the e-mail.

Seroquel is approved in the United States for treatment of schizophrenia and bipolar disorder.

In an e-mailed statement, company spokesman Tony Jewell said: "AstraZeneca has studied Seroquel extensively and shared all relevant and required data with the FDA -- both before and after the agency approved it as safe and effective," Bloomberg reported.

-----

White House to Rescind Health Worker Conscience Rule

A Bush administration rule that gave broad protection to health workers who refuse to take part in abortions or other health care procedures that conflict with their beliefs will be rescinded by the Obama administration, The New York Times reported.

The last-minute Bush law was announced on Dec. 19 and took effect the day President Obama took office last month. On Friday, the Department of Health and Human Services served notice that it will repeal the regulation, the Times reported.

The official notice of the Obama administration's intent is expected to be officially published next week. After that, there will be a 30-day period for public comment.

Opponents of the Bush rule welcomed the decision.

"Today's action by the Obama administration demonstrates that this president is not going to stand by and let women's health be placed in jeopardy," Cecile Richards, president of Planned Parenthood, said Friday.

The group and the attorneys general of several states had filed legal challenges against the Bush regulation, which was also opposed by the American Medical Association and the National Association of Chain Drug Stores, the Times said.

-----

Black Box Warning Ordered For Heartburn Drug

The U.S. Food and Drug Administration's most serious warning will be added to the heartburn drug metoclopramide (brand name Reglan), which has been shown to cause muscle spasms and tics when used for long periods or at high doses, the FDA said.

These problems, including uncontrollable movement of the limbs, face and tongue, are usually irreversible even after patients stop taking the drug, according to the warning, cited by the Associated Press.

The drug is marketed by Schwarz Pharma (tablet form), Baxter International (injectable form) and by a number of generic drug makers. In addition to the black box warning, all manufacturers will be required to provide medication safety guides to users.

Page
  • 1
  • |
  • 2
Join the Discussion
You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.
blog comments powered by Disqus
 
You Might Also Like...